MichaelJamesJamiesonMDFRCP Edin

PubMed

• 6 citations
  Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.
  Michael J Jamieson, Wonkyung Byon, Richard W Dettloff, Matthew Crawford, Peter S Gargalovic, Samira J Merali, Joelle Onorato, Andres J Quintero, Cristina Russ> ;American Journal of Cardiovascular Drugs. 2022 Nov 1
• 10 citations
  Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.
  Keith C. Ferdinand, John M. Flack, Elijah Saunders, Ronald G. Victor, Karol E. Watson, Attila Kursun, Michael J. Jamieson, Harry Shi> ;Journal of Clinical Hypertension. 2009 Oct 1
• 43 citations
  Improved Attainment of Blood Pressure and Cholesterol Goals Using Single-Pill Amlodipine/Atorvastatin in African Americans: The CAPABLE Trial
  John M. Flack, Ronald G. Victor, Karol E. Watson, Keith C. Ferdinand, Elijah Saunders, Lisa Tarasenko, Michael J. Jamieson, Harry Shi, Pia Bruschi> ;Mayo Clinic Proceedings. 2008 Jan 1
• 3 citations
  Multi-constituent cardiovascular pills (MCCP)--challenges and promises of population-based prophylactic drug therapy for prevention of heart attack.
  Michael J. Jamieson, Morteza Naghavi> ;Current Pharmaceutical Design. 2007 Mar 31
• 43 citations
  Effects of High-Dose Atorvastatin in Patients ≥65 Years of Age With Acute Coronary Syndrome (from the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowerin...
  Anders G. Olsson, Gregory G. Schwartz, Michael Szarek, Don Luo, Michael J. Jamieson> ;The American Journal of Cardiology. 2007 Mar 1
• 440 citations
  From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
  Morteza Naghavi, Erling Falk, Harvey S. Hecht, Michael J. Jamieson, Sanjay Kaul, Daniel S. Berman, Zahi A. Fayad, Matthew J. Budoff, John A. Rumberger, Tasneem Z. Naqv...> ;The American Journal of Cardiology. 2006 Jul 17
• Ambulatory blood pressure monitoring may be a prognostic marker in people with heart failure. Commentary 2.
  Michael J. Jamieson> ;Evidence-Based Cardiovascular Medicine. 2005 Aug 1
• 19 citations
  Histamine response and local cooling in the human skin: involvement of H1‐ and H2‐receptors
  M. Grossmann, M. J. Jamieson, Wilhelm Kirch> ;British Journal of Clinical Pharmacology. 1999 Aug 1
• 3 citations
  The local effects of systemic digoxin on the cutaneous microcirculation
  Matthias Grossmann, Michael J. Jamieson, Wilhelm Kirch> ;European Journal of Clinical Pharmacology. 1999 Jun 1
• 14 citations
  Effects of digoxin and digitoxin on circadian blood pressure profile in healthy volunteers
  M. Grossmann, M. J. Jamieson, Wilhelm Kirch> ;European Journal of Clinical Investigation. 1998 Sep 1
• 21 citations
  Evaluation of the IITC tail cuff blood pressure recorder in the rat against intraarterial pressure according to criteria for human devices
  Michael J. Jamieson, Gary M. Gonzales, Thomas I. Jackson, Steven M. Koerth, William F. Romano, Dun Xian Tan, Frank Castillon, Michael H. Skinner, Matthias Grossmann, A...> ;American Journal of Hypertension. 1997 Feb 1
• 82 citations
  The effect of iontophoresis on the cutaneous vasculature : evidence for current-induced hyperemia
  Matthias Grossmann, Michael J. Jamieson, Dean L. Kellogg, Wojciech A. Kosiba, Pablo E. Pergola, Craig G. Crandall, Alexander M. M. Shepherd> ;Microvascular Research. 1995 Nov 1
• Miscompliance by proxy
  Michael J. Jamieson, Lauren Garbutt-Sculli, Alexander M. M. Shepherd> ;Clinical Pharmacology and Therapeutics. 1995 Nov 1
• 1 citations
  Determination of α‐adrenergic blocking potency
  Alexander M. M. Shepherd, Chi Ming Kwan, Carol L Brodie, Michael J. Jamieson> ;Clinical Pharmacology and Therapeutics. 1991 Jan 1
• 9 citations
  Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients
  Stephen H D Jackson, Alexander M. M. Shepherd, Thomas M. Ludden, Michael J. Jamieson, James Woodworth, Dianne Rogers, Lyn K. Ludden, Keith T. Muir> ;Journal of Cardiovascular Pharmacology. 1990 Oct 1
• 1 citations
  Alpha adrenergic blocking activity of urapidil in man.
  Michael J. Jamieson, Alexander M. M. Shepherd, S. H D Jackson, S. S. Patel, P. H. Flanagan, H. Galbraith> ;Research Communications in Chemical Pathology and Pharmacology. 1988 Nov 1
• The analysis of dose-response curves--a practical approach.
  Jackson SH, Jamieson MJ, Johnston A, Shepherd AM> ;Br J Clin Pharmacol. 1987-02-01
• 5 citations
  The assessment of the beta-blocking activity of urapidil: a new method.
  Michael J. Jamieson, S. H D Jackson, S. S. Patel, Alexander M Shepherd, H. Galbraith, W. K. Stewart, P. H. Flanagan> ;European Journal of Clinical Pharmacology. 1986 Jan 1
• A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
  Webster J, Petrie JC, Robb OJ, Jamieson M, Verschueren J> ;Br J Clin Pharmacol. 1985-10-01
• Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
  Jamieson M, Petrie JC, Webster J, Miller A, Harris RI, Francis RJ> ;Eur. J. Clin. Pharmacol.. 1985-01-01
• Nicardipine sustained release in hypertension.
  Webster, J., Petrie, J. C., Jeffers, T. A., Roy-Chaudhury, P., Crichton, W., Witte, K., Jamieson, M., MacDonald, F. C., Beard, M., Dow, R. J.> ;Br J Clin Pharmacol. 1991 Oct
• A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
  Jamieson, M. J., Webster, J., Fowler, G., Rawles, J., Smith, F. W., Petrie, J. C.> ;Br J Clin Pharmacol. 1991 Mar
• 8 citations
  Ambulatory blood pressure in heart failure.
  M. J. Jamieson, Craig Jamieson> ;European Journal of Clinical Investigation. 2001 Apr 1
• Join now to see all